Core Laboratories N.V. (NYSE:CLB) has been given a consensus rating of “Hold” by the seventeen analysts that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and six have issued a buy recommendation on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $108.30.

Several equities research analysts have recently issued reports on the stock. Zacks Investment Research upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Wednesday. UBS AG lowered their price objective on shares of Core Laboratories N.V. from $110.00 to $100.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 25th. ABN Amro upgraded shares of Core Laboratories N.V. from a “hold” rating to a “buy” rating in a research note on Wednesday, October 25th. Loop Capital lowered their price objective on shares of Core Laboratories N.V. from $125.00 to $115.00 and set a “buy” rating on the stock in a research note on Wednesday, October 25th. Finally, Scotiabank set a $136.00 price objective on shares of Core Laboratories N.V. and gave the stock a “hold” rating in a research note on Wednesday, October 25th.

Core Laboratories N.V. (NYSE:CLB) last announced its quarterly earnings data on Monday, October 23rd. The oil and gas company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.44 by $0.04. The business had revenue of $166.20 million for the quarter, compared to the consensus estimate of $160.94 million. Core Laboratories N.V. had a net margin of 12.06% and a return on equity of 52.89%. Core Laboratories N.V.’s quarterly revenue was up 1.4% on a year-over-year basis. During the same quarter last year, the company posted $0.38 earnings per share.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 21st. Shareholders of record on Friday, October 20th will be paid a dividend of $0.55 per share. The ex-dividend date is Thursday, October 19th. This represents a $2.20 dividend on an annualized basis and a yield of 2.16%. Core Laboratories N.V.’s dividend payout ratio is currently 126.44%.

Large investors have recently modified their holdings of the company. Parallel Advisors LLC boosted its stake in shares of Core Laboratories N.V. by 13.1% in the 2nd quarter. Parallel Advisors LLC now owns 1,008 shares of the oil and gas company’s stock valued at $101,000 after purchasing an additional 117 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in shares of Core Laboratories N.V. by 63.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock valued at $114,000 after purchasing an additional 439 shares in the last quarter. Shine Investment Advisory Services Inc. acquired a new stake in shares of Core Laboratories N.V. in the 2nd quarter valued at $134,000. Advisory Services Network LLC boosted its stake in shares of Core Laboratories N.V. by 33.3% in the 2nd quarter. Advisory Services Network LLC now owns 1,365 shares of the oil and gas company’s stock valued at $138,000 after purchasing an additional 341 shares in the last quarter. Finally, First Bank & Trust boosted its stake in shares of Core Laboratories N.V. by 5.8% in the 2nd quarter. First Bank & Trust now owns 1,493 shares of the oil and gas company’s stock valued at $152,000 after purchasing an additional 82 shares in the last quarter.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://www.watchlistnews.com/core-laboratories-n-v-clb-receives-average-recommendation-of-hold-from-analysts/1675918.html.

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.